Northern Trust’s Biogen BIIB Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $265M | Buy |
1,446,579
+453
| +0% | +$83.5K | 0.04% | 407 |
|
|
2025
Q4 | $255M | Sell |
1,446,126
-53,206
| -4% | -$8.69M | 0.03% | 413 |
|
|
2025
Q3 | $210M | Sell |
1,499,332
-37,648
| -2% | -$5.09M | 0.03% | 478 |
|
|
2025
Q2 | $193M | Buy |
1,536,980
+35,893
| +2% | +$4.47M | 0.03% | 496 |
|
|
2025
Q1 | $205M | Sell |
1,501,087
-49,043
| -3% | -$7.01M | 0.03% | 463 |
|
|
2024
Q4 | $237M | Buy |
1,550,130
+196,995
| +15% | +$33.2M | 0.03% | 436 |
|
|
2024
Q3 | $262M | Sell |
1,353,135
-72,786
| -5% | -$15.2M | 0.04% | 368 |
|
|
2024
Q2 | $331M | Buy |
1,425,921
+37,535
| +3% | +$8.16M | 0.06% | 298 |
|
|
2024
Q1 | $299M | Sell |
1,388,386
-106,577
| -7% | -$25M | 0.05% | 327 |
|
|
2023
Q4 | $387M | Sell |
1,494,963
-148,072
| -9% | -$36.4M | 0.07% | 260 |
|
|
2023
Q3 | $422M | Buy |
1,643,035
+45,437
| +3% | +$12.2M | 0.08% | 222 |
|
|
2023
Q2 | $455M | Sell |
1,597,598
-73,691
| -4% | -$21.9M | 0.09% | 210 |
|
|
2023
Q1 | $465M | Sell |
1,671,289
-380
| -0% | -$105K | 0.09% | 214 |
|
|
2022
Q4 | $463M | Sell |
1,671,669
-13,352
| -0.8% | -$3.77M | 0.1% | 210 |
|
|
2022
Q3 | $450M | Sell |
1,685,021
-24,556
| -1% | -$5.22M | 0.1% | 185 |
|
|
2022
Q2 | $349M | Buy |
1,709,577
+24,050
| +1% | +$4.92M | 0.07% | 254 |
|
|
2022
Q1 | $355M | Sell |
1,685,527
-6,595
| -0.4% | -$1.43M | 0.06% | 295 |
|
|
2021
Q4 | $406M | Sell |
1,692,122
-66,768
| -4% | -$17.2M | 0.07% | 281 |
|
|
2021
Q3 | $498M | Sell |
1,758,890
-308,649
| -15% | -$101M | 0.09% | 206 |
|
|
2021
Q2 | $716M | Sell |
2,067,539
-52,969
| -2% | -$16M | 0.13% | 145 |
|
|
2021
Q1 | $593M | Sell |
2,120,508
-80,450
| -4% | -$21.7M | 0.11% | 165 |
|
|
2020
Q4 | $539M | Sell |
2,200,958
-182,232
| -8% | -$47M | 0.11% | 170 |
|
|
2020
Q3 | $676M | Sell |
2,383,190
-54,446
| -2% | -$15.2M | 0.15% | 132 |
|
|
2020
Q2 | $652M | Sell |
2,437,636
-33,166
| -1% | -$9.97M | 0.15% | 128 |
|
|
2020
Q1 | $782M | Sell |
2,470,802
-20,459
| -0.8% | -$6.21M | 0.22% | 86 |
|
|
2019
Q4 | $739M | Sell |
2,491,261
-301,394
| -11% | -$83.6M | 0.17% | 123 |
|
|
2019
Q3 | $650M | Sell |
2,792,655
-90,235
| -3% | -$21M | 0.16% | 130 |
|
|
2019
Q2 | $674M | Sell |
2,882,890
-16,277
| -0.6% | -$3.76M | 0.16% | 126 |
|
|
2019
Q1 | $685M | Sell |
2,899,167
-8,139
| -0.3% | -$2.56M | 0.17% | 117 |
|
|
2018
Q4 | $875M | Buy |
2,907,306
+133,137
| +5% | +$42.5M | 0.25% | 84 |
|
|
2018
Q3 | $980M | Sell |
2,774,169
-118,390
| -4% | -$40.8M | 0.24% | 83 |
|
|
2018
Q2 | $840M | Buy |
2,892,559
+19,730
| +0.7% | +$5.55M | 0.21% | 91 |
|
|
2018
Q1 | $787M | Sell |
2,872,829
-106,511
| -4% | -$33.1M | 0.2% | 98 |
|
|
2017
Q4 | $949M | Sell |
2,979,340
-49,407
| -2% | -$15.9M | 0.24% | 82 |
|
|
2017
Q3 | $948M | Buy |
3,028,747
+11,611
| +0.4% | +$3.44M | 0.25% | 75 |
|
|
2017
Q2 | $819M | Buy |
3,017,136
+223,371
| +8% | +$59.1M | 0.23% | 88 |
|
|
2017
Q1 | $764M | Sell |
2,793,765
-70
| -0% | -$19.8K | 0.22% | 89 |
|
|
2016
Q4 | $792M | Sell |
2,793,835
-184,644
| -6% | -$54.7M | 0.24% | 76 |
|
|
2016
Q3 | $932M | Buy |
2,978,479
+12,483
| +0.4% | +$3.7M | 0.29% | 66 |
|
|
2016
Q2 | $717M | Sell |
2,965,996
-36,996
| -1% | -$9.75M | 0.23% | 85 |
|
|
2016
Q1 | $788M | Sell |
3,002,992
-22,269
| -0.7% | -$5.88M | 0.26% | 70 |
|
|
2015
Q4 | $927M | Sell |
3,025,261
-143,733
| -5% | -$41.3M | 0.31% | 67 |
|
|
2015
Q3 | $925M | Buy |
3,168,994
+69,554
| +2% | +$23M | 0.31% | 68 |
|
|
2015
Q2 | $1.25B | Sell |
3,099,440
-21,411
| -0.7% | -$8.59M | 0.38% | 55 |
|
|
2015
Q1 | $1.32B | Sell |
3,120,851
-24,405
| -0.8% | -$9.62M | 0.4% | 52 |
|
|
2014
Q4 | $1.07B | Sell |
3,145,256
-78,567
| -2% | -$25.4M | 0.32% | 60 |
|
|
2014
Q3 | $1.07B | Buy |
3,223,823
+75,201
| +2% | +$24.8M | 0.33% | 55 |
|
|
2014
Q2 | $993M | Sell |
3,148,622
-157,094
| -5% | -$47.3M | 0.31% | 58 |
|
|
2014
Q1 | $1.01B | Buy |
3,305,716
+103,600
| +3% | +$32.9M | 0.32% | 57 |
|
|
2013
Q4 | $895M | Sell |
3,202,116
-13,226
| -0.4% | -$3.42M | 0.29% | 70 |
|
|
2013
Q3 | $774M | Sell |
3,215,342
-130,336
| -4% | -$29.2M | 0.27% | 76 |
|
|
2013
Q2 | $720M | Buy |
+3,345,678
| New | +$715M | 0.26% | 79 |
|
Other funds holding BIIB
VCM
VPM
Northern Trust's BIIB Position: Q1 2026 in Review
Northern Trust increased its Biogen (BIIB) stake by 0.03% in Q1 2026, buying an estimated $83.5K and bringing the position to 1,446,579 shares worth $265M. The position accounts for 0.04% of the portfolio, ranked #407.
Northern Trust first reported a position in BIIB in Q2 2013 and has held it in 52 quarters since. The position peaked at $1.32B in Q1 2015. 1,002 funds tracked by Wall St. Rank hold BIIB as of Q1 2026.
- Northern Trust held 1,446,579 shares of Biogen worth $265M as of Q1 2026.
- Northern Trust bought 453 Biogen shares in Q1 2026, an estimated $83.5K.
- Biogen made up 0.04% of Northern Trust's portfolio in Q1 2026, its #407 holding.
- Northern Trust first reported a position in Biogen in Q2 2013 and has held it in 52 quarters since.
- Northern Trust's Biogen position peaked at $1.32B in Q1 2015.
- 1,002 funds tracked by Wall St. Rank held Biogen as of Q1 2026.
Based on Northern Trust's 13F filing for Q1 2026, filed 14 May 2026.